KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to 0.36%.

  • Moderna's Return on Invested Capital fell 1600.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.31% for FY2024, which is 100.0% down from last year.
  • Per Moderna's latest filing, its Return on Invested Capital stood at 0.36% for Q3 2025, which was down 1600.0% from 0.33% recorded in Q2 2025.
  • Moderna's 5-year Return on Invested Capital high stood at 0.96% for Q4 2021, and its period low was 0.49% during Q2 2024.
  • Over the past 5 years, Moderna's median Return on Invested Capital value was 0.04% (recorded in 2023), while the average stood at 0.13%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first soared by 12300bps in 2021, then plummeted by -8600bps in 2023.
  • Moderna's Return on Invested Capital (Quarter) stood at 0.96% in 2021, then tumbled by -56bps to 0.42% in 2022, then tumbled by -185bps to 0.35% in 2023, then increased by 7bps to 0.33% in 2024, then dropped by -10bps to 0.36% in 2025.
  • Its Return on Invested Capital stands at 0.36% for Q3 2025, versus 0.33% for Q2 2025 and 0.35% for Q1 2025.